SFA Therapeutics

Biotechnology Research • Jenkintown, Pennsylvania, United States • 1-10 Employees

Company overview

Headquarters	610 Old York Rd, Suite 400, Jenkintown, Pennsylvania 19046, US
Phone number	+12675841080
Website	sfatherapeutics.com
SIC	283
Employees	1-10
Socials

Key Contacts at SFA Therapeutics

Ira Spector

Ceo

Ira Spector

Chief Executive Officer

SFA Therapeutics Email Formats

SFA Therapeutics uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@sfatherapeutics.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@sfatherapeutics.com	100%

About SFA Therapeutics

SFA Therapeutics is a clinical stage start-up biotech company with a platform technology based on Nobel Prize winning research. This patented and proprietary platform is based on the immuno-modulation of inflammatory factors through innate T-Regulatory (Treg) cell differentiation. The technology is licensed from and supported by research at Temple University in Philadelphia. The result is a unique native immunotherapy platform with activity currently being investigated in cancer, liver, and auto-immune disease.

SFA Therapeutics revenue & valuation

Annual revenue	$500,000
Revenue per employee	$63,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,600,000
Total funding	$9,000,000